Seroba
Seroba is a life sciences venture capital firm that focuses on investing in healthcare technologies.
Business Model:
Revenue: $4.8M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Seroba Information
Geographic Data
Address: 18 Herbert Street
City: Dublin
State: county dublin
Zip:
Country: IE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$108M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Seroba is a life sciences venture capital firm that focuses on investing in healthcare technologies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2021 | Coave Therapeutics | Series B | 0 |
| 6/2020 | Shorla Pharma | Series A | 8.3M |
| 4/2023 | Complement Therapeutics | Series A | 0 |
| 2/2005 | Opsona | Series A | 6.6M |
| 2/2009 | Opsona | Series B | 22.8M |
| 2/2017 | Prexton Therapeutics | Series B | 31.1M |
| 3/2017 | Medlumics | Series B | 36.9M |
| 5/2011 | Novate Medical | Series B | 12.4M |
| 2/2022 | Perfuze | Series A | 0 |
| 1/2019 | PQ Bypass | Private Equity Round | 0 |
| 12/2010 | Provesica | Venture Round | 6.2M |
| 6/2005 | TriMed Research | Venture Round | 6.1M |
| 12/2011 | Biosensia | Venture Round | 1.6M |
| 3/2021 | INNOVO by Atlantic Therapeutics | Venture Round | - |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 4/2014 | Heart Metabolics | Series A | 20M |
| 1/2019 | INNOVO by Atlantic Therapeutics | Series B | 32.1M |
| 5/2019 | Storm Therapeutics | Series A | 17.8M |
| 12/2022 | Storm Therapeutics | Series B | 30M |
| 2/2008 | Biosensia | Venture Round | 0 |
| 6/2021 | Quanta | Series D | 0 |
| 3/2017 | INNOVO by Atlantic Therapeutics | Series A | 15.8M |
| 10/2022 | Sibylla Biotech | Series A | 0 |
| 1/2015 | Veryan Medical | Series B | 0 |
| 1/2023 | Deciphex | Series B | 4.2M |
| 4/2010 | Veryan Medical | Series A | 5.4M |
| 6/2009 | Opsona | Series B | 4.6M |
| 9/2017 | Fusion Pharmaceuticals | Series A | 0 |
| 11/2010 | Covagen | Series A | 6.3M |
| 12/2013 | Covagen | Series B | 0 |
| 9/2018 | Endotronix | Series D | 0 |
| 10/2011 | Veryan Medical | Venture Round | 8.1M |
| 7/2019 | Quanta | Series C | 0 |
| 11/2014 | Quanta | Series B | 43.1M |
| 6/2021 | Palliare | Series A | 0 |
| 6/2005 | Diabetica | Series A | 1.2M |
| 1/2014 | Apica Cardiovascular | Venture Round | 1.5M |
| 11/2009 | Quanta | Series A | 14.3M |
| 2/2022 | Perfuze | Series A | 0 |
| 7/2021 | Coave Therapeutics | Series B | 0 |
| 6/2021 | Palliare | Series A | 0 |
| 6/2021 | Quanta | Series D | 0 |
| 3/2021 | INNOVO by Atlantic Therapeutics | Venture Round | - |
| 6/2020 | Shorla Pharma | Series A | 0 |
| 7/2019 | Quanta | Series C | 0 |
| 5/2019 | Storm Therapeutics | Series A | 0 |
| 4/2019 | Fusion Pharmaceuticals | Series B | 0 |
| 1/2019 | PQ Bypass | Private Equity Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2017 | Investment Fund | $107.8M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
